Download video

Phase I/II study of nivolumab and axitinib for advanced RCC

104 views

VJOncology

3 years ago

Phase I/II study of nivolumab and axitinib for advanced RCC

Phase I/II study of nivolumab and axitinib for advanced RCC

Phase I\/II study of nivolumab and axitinib for advanced RCC
1:29
Phase I\/II study of nivolumab and axitinib for advanced RCC
by VJOncology
Overview of a Phase III Trial of Pembrolizumab Plus Axitinib in RCC
2:23
Overview of a Phase III Trial of Pembrolizumab Plus Axitinib in RCC
by Targeted Oncology
Avelumab and axitinib for the treatment of advanced RCC
0:57
Avelumab and axitinib for the treatment of advanced RCC
by VJOncology
Study on avelumab and axitinib vs sunitinib in the treatment of advanced renal cell carcinoma
9:30
Study on avelumab and axitinib vs sunitinib in the treatment of advanced renal cell carcinoma
by ecancer
Axitinib plus pembrolizumab in advanced RCC
2:31
Axitinib plus pembrolizumab in advanced RCC
by VJOncology
Combining avelumab and axitinib in advanced renal cell carcinoma (RCC)
2:27
Combining avelumab and axitinib in advanced renal cell carcinoma (RCC)
by VJOncology
Pembrolizumab monotherapy and pembro-axitinib for RCC
2:18
Pembrolizumab monotherapy and pembro-axitinib for RCC
by VJOncology
Immunotherapy in Renal Cell Carcinoma
39:34
Immunotherapy in Renal Cell Carcinoma
by UBC Urology Rounds
Phase 3 Axitinib Data in patients with previously treated advanced renal cell carcinoma
9:52
Phase 3 Axitinib Data in patients with previously treated advanced renal cell carcinoma
by Oncology.TV
Dr. Vaishampayan on Axitinib Plus Pembrolizumab in Advanced RCC
1:17
Dr. Vaishampayan on Axitinib Plus Pembrolizumab in Advanced RCC
by OncLive
Two Positive Phase III RCC Studies, Nivolumab Approved for NSCLC in Europe, and More
4:15
Two Positive Phase III RCC Studies, Nivolumab Approved for NSCLC in Europe, and More
by OncLive
Real-world treatment outcomes of 1L axitinib + pembrolizumab in patients with advanced RCC in the US
5:10
Real-world treatment outcomes of 1L axitinib + pembrolizumab in patients with advanced RCC in the US
by VJOncology
Pembrolizumab\/Axitinib and Avelumab\/Axitinib combo for RCC
1:00
Pembrolizumab\/Axitinib and Avelumab\/Axitinib combo for RCC
by VJOncology
Dr. Hutson Discusses the Phase III ATLAS Study in RCC
1:03
Dr. Hutson Discusses the Phase III ATLAS Study in RCC
by OncLive
Avelumab and axitinib vs sunitinib in treating advanced renal cell carcinoma
4:39
Avelumab and axitinib vs sunitinib in treating advanced renal cell carcinoma
by ecancer
AGILE Trial: Frontline Axitinib Versus Sorafenib in Metastatic Renal Cell Carcinoma
3:57
AGILE Trial: Frontline Axitinib Versus Sorafenib in Metastatic Renal Cell Carcinoma
by OncLive
COSMIC-313: cabo + nivo + ipi in 1L advanced RCC of IMDC intermediate or poor risk
4:01
COSMIC-313: cabo + nivo + ipi in 1L advanced RCC of IMDC intermediate or poor risk
by VJOncology
Dr. Rini on Axitinib for Treatment of Metastatic Renal Cell Carcinoma
2:16
Dr. Rini on Axitinib for Treatment of Metastatic Renal Cell Carcinoma
by OncLive
Dr. Rini on Pembrolizumab Plus Axitinib in RCC
1:34
Dr. Rini on Pembrolizumab Plus Axitinib in RCC
by OncLive
Nivolumab with alternatively scheduled ipilimumab in first-line treatment of advanced RCC
9:09
Nivolumab with alternatively scheduled ipilimumab in first-line treatment of advanced RCC
by ecancer